. 2017 Jun;18(6):474–480. doi: 10.1631/jzus.B1600133

Table 3.

Effects of different treatments on the body weight of mice

Group	Body weight (g)
Group	1 d	4 d	7 d	9 d	12 d
A	20.39±1.22^a	23.61±0.51^a	26.85±1.47^a	24.00±0.41^a	26.47±0.44^a
B	20.20±0.68^a	21.59±0.23^ab	23.26±0.49^b	25.53±0.64^a	28.05±1.12^a
C	19.25±0.88^a	20.27±0.47^b	22.04±0.54^b	21.10±0.78^b	22.26±0.43^b
D	20.55±0.25^a	21.18±1.41^b	23.87±0.26^b	21.39±0.55^b	22.75±0.57^b
E	19.94±0.32^a	20.56±0.63^b	22.23±0.40^b	21.83±0.29^b	22.49±0.45^b
F	20.06±0.33^a	21.10±0.32^b	23.02±0.31^b	22.18±0.64^b	23.00±0.68^b
G	20.74±0.28^a	21.04±1.17^b	23.90±0.56^b	21.04±0.51^b	22.53±0.27^b

A, CM-Pal prevention group; B, uninfected group; C, Pal group; D, montmorillonite powder group; E, CM-Pal treatment group; F, gentamicin group; G, no treatment group. Within columns, different superscripts (a–b) indicate a significant difference (P<0.05)